Aidapak Services LLC, Select Repackaged Pharmaceuticals: Recall - Potential Incorrect Labeling
Aidapak Services LLC, Specific Unit Dose Repackaged Products: Recall - Potential Incorrect Labeling
Italiano
Aidapak Services LLC, Specific Unit Dose Repackaged Products: Recall - Potential Incorrect Labeling
The risk of peripheral neuropathy occurs only with fluoroquinolones that are taken by mouth or by injection.
Spillage of the blood and blood products stored in the bag may result in delay/interruption in therapy or exposure to the healthcare professional.
Increased risk of over-infusion or under-infusion if the infusion is started with the incorrect rate. This can cause serious adverse health consequences, including death.
Bacterial infections have been potentially associated with contaminated calcium gluconate infusions.
The company is making corrections and improvements to the device labeling to minimize likelihood of implanting the filter backwards.
Device malfunction can result in the sudden unintended discontinuation of medications. This can lead to cause serious adverse health consequences, including death.
Consuming this product potentially could result in dizziness and cause public health risk.
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk.
Sibutramine and Phenolphthalein may pose health threats or interact in life-threatening ways with other medications a consumer may be taking.
80.211.154.110